RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 101 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $5,613,563 | +4.8% | 3,792,499 | +2.7% | 0.00% | 0.0% |
| Q4 2023 | $5,355,011 | +39.8% | 3,692,699 | +4.1% | 0.00% | – |
| Q3 2023 | $3,831,358 | -12.8% | 3,547,100 | +4.1% | 0.00% | -100.0% |
| Q2 2023 | $4,395,094 | +1.7% | 3,407,050 | +4.0% | 0.00% | 0.0% |
| Q1 2023 | $4,322,460 | +91400.0% | 3,274,591 | +4.0% | 0.00% | 0.0% |
| Q4 2022 | $4,724 | -99.9% | 3,149,470 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $3,641,000 | +5.0% | 3,086,408 | +0.6% | 0.00% | 0.0% |
| Q2 2022 | $3,467,000 | -62.1% | 3,068,459 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $9,148,000 | +10.9% | 3,059,728 | -1.7% | 0.00% | 0.0% |
| Q4 2021 | $8,248,000 | -26.8% | 3,112,660 | +0.2% | 0.00% | -50.0% |
| Q3 2021 | $11,273,000 | -12.8% | 3,105,540 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $12,929,000 | +35.4% | 2,979,126 | +6.7% | 0.00% | +100.0% |
| Q1 2021 | $9,551,000 | +4.9% | 2,792,937 | +7.4% | 0.00% | -50.0% |
| Q4 2020 | $9,101,000 | +48.5% | 2,600,312 | +1.8% | 0.00% | +100.0% |
| Q3 2020 | $6,128,000 | +34.0% | 2,553,615 | +2.2% | 0.00% | 0.0% |
| Q2 2020 | $4,573,000 | +20.5% | 2,499,379 | +2.7% | 0.00% | 0.0% |
| Q1 2020 | $3,796,000 | -60.7% | 2,433,581 | -46.1% | 0.00% | 0.0% |
| Q4 2019 | $9,668,000 | +121.3% | 4,518,510 | +93.4% | 0.00% | 0.0% |
| Q3 2019 | $4,368,000 | -27.6% | 2,335,865 | +1.0% | 0.00% | 0.0% |
| Q2 2019 | $6,034,000 | +15.6% | 2,312,155 | +13.9% | 0.00% | 0.0% |
| Q1 2019 | $5,218,000 | -41.2% | 2,030,430 | -47.4% | 0.00% | 0.0% |
| Q4 2018 | $8,874,000 | +67.6% | 3,858,376 | +133.9% | 0.00% | 0.0% |
| Q3 2018 | $5,295,000 | +13.5% | 1,649,772 | +0.1% | 0.00% | 0.0% |
| Q2 2018 | $4,664,000 | +3.3% | 1,648,253 | +29.3% | 0.00% | 0.0% |
| Q1 2018 | $4,513,000 | -6.9% | 1,275,104 | +2.1% | 0.00% | -50.0% |
| Q4 2017 | $4,847,000 | +81.2% | 1,249,380 | +18.6% | 0.00% | +100.0% |
| Q3 2017 | $2,675,000 | -5.0% | 1,053,500 | +2.1% | 0.00% | 0.0% |
| Q2 2017 | $2,815,000 | -16.0% | 1,031,371 | +1.9% | 0.00% | 0.0% |
| Q1 2017 | $3,350,000 | +84.9% | 1,012,241 | +32.9% | 0.00% | 0.0% |
| Q4 2016 | $1,812,000 | -38.5% | 761,672 | -5.1% | 0.00% | 0.0% |
| Q3 2016 | $2,946,000 | +76.7% | 802,861 | +7.3% | 0.00% | 0.0% |
| Q2 2016 | $1,667,000 | +9.7% | 747,946 | +2.3% | 0.00% | 0.0% |
| Q1 2016 | $1,520,000 | -23.5% | 731,016 | +11.5% | 0.00% | 0.0% |
| Q4 2015 | $1,986,000 | +39.3% | 655,695 | +13.5% | 0.00% | 0.0% |
| Q3 2015 | $1,426,000 | -19.0% | 577,561 | +5.3% | 0.00% | 0.0% |
| Q2 2015 | $1,760,000 | -8.6% | 548,450 | +1.6% | 0.00% | 0.0% |
| Q1 2015 | $1,926,000 | +84.8% | 539,695 | +17.5% | 0.00% | 0.0% |
| Q4 2014 | $1,042,000 | +21.9% | 459,326 | +4.2% | 0.00% | 0.0% |
| Q3 2014 | $855,000 | -46.1% | 440,779 | +0.8% | 0.00% | 0.0% |
| Q2 2014 | $1,587,000 | -5.6% | 437,345 | +0.8% | 0.00% | 0.0% |
| Q1 2014 | $1,682,000 | +40.8% | 433,672 | +3.4% | 0.00% | 0.0% |
| Q4 2013 | $1,195,000 | -19.5% | 419,300 | +1.1% | 0.00% | 0.0% |
| Q3 2013 | $1,485,000 | +25.1% | 414,741 | +16.7% | 0.00% | 0.0% |
| Q2 2013 | $1,187,000 | – | 355,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,550,000 | $14,606,000 | 4.17% |
| Sio Capital Management, LLC | 1,843,501 | $5,918,000 | 2.03% |
| Sofinnova Investments, Inc. | 3,260,931 | $10,467,000 | 0.93% |
| Boxer Capital, LLC | 2,321,900 | $7,453,000 | 0.83% |
| Rhenman & Partners Asset Management AB | 2,113,988 | $6,786,000 | 0.68% |
| Palo Alto Investors LP | 3,966,087 | $12,731,000 | 0.52% |
| Rock Springs Capital Management LP | 4,125,000 | $13,241,000 | 0.48% |
| NEA Management Company, LLC | 3,243,150 | $10,411,000 | 0.45% |
| B. Riley Financial, Inc. | 473,343 | $1,519,000 | 0.43% |
| Walleye Capital LLC | 151,923 | $488,000 | 0.23% |